Latest Articles
Prognosis of premenopausal women with low-risk endometrial cancer but elevated CA125 levels - Frontiers
Prognosis of premenopausal women with low-risk endometrial cancer but elevated CA125 levels Frontiers
Published: Dec. 26, 2024, 4:01 p.m.
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment - Frontiers
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment Frontiers
Published: Dec. 24, 2024, 7:10 p.m.
Research Bolsters Need for Enhanced Surveillance After Radiotherapy for Endometrial Cancer - Oncology Nurse Advisor
Research Bolsters Need for Enhanced Surveillance After Radiotherapy for Endometrial Cancer Oncology Nurse Advisor
Published: Dec. 23, 2024, 5 p.m.
QOL With Shorter RT Equal to Standard in Endometrial Cancer - Medscape
QOL With Shorter RT Equal to Standard in Endometrial Cancer Medscape
Published: Dec. 23, 2024, 1:27 p.m.
Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides - Nature.com
Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides Nature.com
Published: Dec. 21, 2024, 9:20 a.m.
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer - Nature.com
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer Nature.com
Published: Dec. 20, 2024, 10:34 a.m.
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today
Published: Dec. 18, 2024, 8:16 p.m.
ASCO Reading Room | The Evolving Treatment Landscape for High-Risk Endometrial Cancer - Medpage Today
ASCO Reading Room | The Evolving Treatment Landscape for High-Risk Endometrial Cancer Medpage Today
Published: Dec. 18, 2024, 3:59 p.m.
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - Medpage Today
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer Medpage Today
Published: Dec. 18, 2024, 3:27 p.m.
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use - PMLiVE
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use PMLiVE
Published: Dec. 18, 2024, 12:25 p.m.
Link copied to clipboard!